Literature DB >> 11388608

Rodent malarias: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite.

C Li1, E Seixas, J Langhorne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11388608     DOI： 10.1007/s430-001-8017-8

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  38 in total

1.  Genome-wide polymorphisms and development of a microarray platform to detect genetic variations in Plasmodium yoelii.

Authors:  Sethu C Nair; Sittiporn Pattaradilokrat; Martine M Zilversmit; Jennifer Dommer; Vijayaraj Nagarajan; Melissa T Stephens; Wenming Xiao; John C Tan; Xin-Zhuan Su
Journal:  Mol Biochem Parasitol       Date:  2014-03-29       Impact factor: 1.759

2.  Splenic gammadelta T cells regulated by CD4+ T cells are required to control chronic Plasmodium chabaudi malaria in the B-cell-deficient mouse.

Authors:  Henri C van der Heyde; Joan M Batchelder; Matyas Sandor; William P Weidanz
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.

Authors:  Kathleen R Page; Anne E Jedlicka; Benjamin Fakheri; Gregory S Noland; Anup K Kesavan; Alan L Scott; Nirbhay Kumar; Yukari C Manabe
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  New potential antimalarial agents: therapeutic-index evaluation of pyrroloquinazolinediamine and its prodrugs in a rat model of severe malaria.

Authors:  Lisa H Xie; Qigui Li; Ai J Lin; Kirsten Smith; Jing Zhang; Donald S Skillman
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

5.  High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology.

Authors:  Ashraful Haque; Shannon E Best; Fiona H Amante; Anne Ammerdorffer; Fabian de Labastida; Tamara Pereira; Grant A Ramm; Christian R Engwerda
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

6.  The course of a primary infection of Plasmodium yoelii 17XL in both 129S1 and IFN-γ receptor-deficient mice.

Authors:  Akira Ishih; Toshi Nagata; Fumie Kobayashi
Journal:  Parasitol Res       Date:  2012-03-06       Impact factor: 2.289

7.  CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.

Authors:  Thomas Rummel; Joan Batchelder; Patrick Flaherty; GayeLyn LaFleur; Payal Nanavati; James M Burns; William P Weidanz
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  On the control of acute rodent malaria infections by innate immunity.

Authors:  Beth F Kochin; Andrew J Yates; Jacobus C de Roode; Rustom Antia
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

9.  Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.

Authors:  Patricia A Reis; Clarissa M Comim; Fernanda Hermani; Bruno Silva; Tatiana Barichello; Aline C Portella; Flavia C A Gomes; Ive M Sab; Valber S Frutuoso; Marcus F Oliveira; Patricia T Bozza; Fernando A Bozza; Felipe Dal-Pizzol; Guy A Zimmerman; João Quevedo; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

10.  Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies.

Authors:  Ching Li; Latifu A Sanni; Fakhreldin Omer; Eleanor Riley; Jean Langhorne
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.